Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic landscape of 891 RET fusions detected across diverse solid tumor types. | NPJ Precis Oncol | 2023 | 36690680 | PubTator, text mining | PubMed |
| The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer. | Nat Commun | 2023 | 36690626 | PubTator, text mining | PubMed |
| Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis. | Br J Dermatol | 2023 | 36689509 | PubTator, text mining | PubMed |
| Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. | J Exp Clin Cancer Res | 2023 | 36683050 | PubTator, text mining | PubMed |
| Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study. | Lancet Oncol | 2023 | 36681091 | PubTator, text mining | PubMed |
| DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities. | Cancers (Basel) | 2023 | 36672401 | PubTator, text mining | PubMed |
| Evaluation of Microsatellite Instability Molecular Analysis versus Immuno-Histochemical Interpretation in Malignant Neoplasms with Different Localizations. | Cancers (Basel) | 2023 | 36672302 | PubTator, text mining | PubMed |
| ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms. | Sci Rep | 2023 | 36650267 | PubTator, text mining | PubMed |
| Characterisation of Colorectal Cancer Cell Lines through Proteomic Profiling of Their Extracellular Vesicles. | Proteomes | 2023 | 36648961 | PubTator, text mining | PubMed |
| Whole-exome sequencing of rectal neuroendocrine tumors. | Endocr Relat Cancer | 2023 | 36645718 | PubTator, text mining | PubMed |
| Visualizing and accessing correlated SAXS data sets with Similarity Maps and Simple Scattering web resources. | Methods Enzymol | 2023 | 36641216 | PubTator, text mining | PubMed |
| Exploring pradimicin-IRD antineoplastic mechanisms and related DNA repair pathways. | Chem Biol Interact | 2023 | 36634904 | PubTator, text mining | PubMed |
| Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing. | JCO Precis Oncol | 2023 | 36634299 | PubTator, text mining | PubMed |
| Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study. | J Med Genet | 2023 | 36627197 | PubTator, text mining | PubMed |
| Unexplained mismatch repair deficiency: Case closed. | HGG Adv | 2023 | 36624813 | PubTator, text mining | PubMed |
| Resolution of sequence divergence for repeat-mediated deletions shows a polarity that is mediated by MLH1. | Nucleic Acids Res | 2023 | 36620890 | PubTator, text mining | PubMed |
| Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. | J Neurooncol | 2023 | 36604386 | PubTator, text mining | PubMed |
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914). | J Gynecol Oncol | 2023 | 36562136 | PubTator, text mining | PubMed |
| WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures. | EMBO J | 2023 | 36541070 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study. | Mol Genet Genomic Med | 2023 | 36537080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=21